Category: ACN Newswire

Edvantage Group Announces FY2024 Annual Results

acn

Highlights (relevant audited data for the year ended 31 August 2024) – Revenue increased by 17% YoY to approximately RMB2,312 million;– Gross profit rose by 10% YoY to approximately RMB1,124 million;– Profit for the period attributable to owners of the Company rose by 16% YoY to      approximately RMB715 million;– Number of student enrolments […]

The Hong Kong Institute of Directors Announces Winners

acn

HONG KONG, Nov 29, 2024 – (ACN Newswire via SeaPRwire.com) – The Hong Kong Institute of Directors (“HKIoD”) announced the winners of its Award Series for Director Excellence (the “Awards”) – comprising the long-established Directors of the Year Awards (“DYA”) and the inaugural Climate Governance Awards (“CGA”), at its Annual Dinner yesterday at the Hong […]

Spritzer Clinches 10th Consecutive “Brand of the Year” Award at the World Branding Awards in London

acn

LONDON, Dec 2, 2024 – (ACN Newswire via SeaPRwire.com) – Spritzer has once again demonstrated its dominance in the bottled water industry by being named “Brand of the Year” in the national beverage division’s Water Category at the prestigious 2024–2025 World Branding Awards. The recognition marks Spritzer’s 10th consecutive win at the global awards, a testament […]

Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong

acn

SHANGHAI, Dec 2, 2024 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Government of the Hong Kong Special Administrative Region, China, has accepted Everest’s New Drug Application […]

Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC

acn

SHANGHAI, Nov 30, 2024 – (ACN Newswire via SeaPRwire.com) – Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity at the 9th China BioMed Innovation and Investment Conference (CBIIC). The SENSITIZE study was initiated […]

香港董事学会公布2024年董事嘉奖系列得主

acn

香港, 2024年11月29日 – (亚太商讯 via SeaPRwire.com) – 香港董事学会昨晚在香港会议及展览中心举行的香港董事学会周年晚宴上公布2024年度董事嘉奖系列得奖者。奖项系列包括历来备受推祟的「杰出董事奬」及今年最新启动的「气候管治奖」。 香港董事学会主席陶荣博士致辞并掀…

NEFECON(R) Included in National Reimbursement Drug List (NRDL)

acn

HONG KONG, Nov 29, 2024 – (ACN Newswire via SeaPRwire.com) – On November 28, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security announced the “National Reimbursement Drug List (2024)” (NRDL), which will officially take effect on January 1, 2025. NEFECON(R), the first etiological treatment for IgA nephropathy developed […]

耐赋康(R)纳入新版国家医保药品目录

acn

香港, 2024年11月29日 – (亚太商讯 via SeaPRwire.com) – 11月28日，国家医疗保障局和人力资源与社会保障部发布了《国家基本医疗保险、工伤保险和生育保险药品目录（2024年）》（以下简称”国家医保药品目录”），并宣布新版目录将于2025年1…

Dmall Inc. Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

acn

HONG KONG, Nov 28, 2024 – (ACN Newswire via SeaPRwire.com) – China’s largest retail digitalization solution provider– Dmall Inc. (“Dmall” or the “Company”, Stock Code: 02586.HK), today announced the proposed listing of its shares on the Main Board of The Stock Exchange of Hong Kong Limited (“Hong Kong Stock Exchange”). Dmall plans to offer 25,774,000 […]